GENERAL ATLANTIC, L.P. CNTA Holdings History
GENERAL ATLANTIC, L.P.'s Centessa Pharmaceuticals PLC Holding Summary
As of 2025-03-31, GENERAL ATLANTIC, L.P. held 9.68 Mil shares of Centessa Pharmaceuticals PLC(CNTA), totaling $139.22 Mil. This investment constitutes 4.67% of their stock portfolio, and GENERAL ATLANTIC, L.P. now holds 7.25% of the outstanding Centessa Pharmaceuticals PLC(CNTA) stock.
The initial trade took place in 2021Q2. And since then GENERAL ATLANTIC, L.P. has made 2 purchases of CNTA, at an average price of $21.17, for a total of 9.68 Mil shares. Based on historical transaction data and CNTA's current price of $15.69, GENERAL ATLANTIC, L.P.'s estimated gain on his CNTA holdings is $-53.09 Mil, reflecting a -25.90% gain to date.
GENERAL ATLANTIC, L.P. CNTA ($15.69) Holding Chart
GENERAL ATLANTIC, L.P. CNTA ($15.69) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
